Reached a peak upstream concentration of 5.8 g/L at the 500L scale, representing a 2.7-fold increase from baseline.
The future of bioprocess development for mAbs is exciting, with several emerging trends and technologies, including: A Mab A Case Study In Bioprocess Development
During the bioprocess development of A Mab, several challenges were encountered, including: Reached a peak upstream concentration of 5
Reached a peak upstream concentration of 5.8 g/L at the 500L scale, representing a 2.7-fold increase from baseline.
The future of bioprocess development for mAbs is exciting, with several emerging trends and technologies, including:
During the bioprocess development of A Mab, several challenges were encountered, including: